Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Fortitech, Inc. Continues Corporate Growth With Key Staff Appointments
Fortitech, Inc., is pleased to announce the addition of Thomas Morba as its new purchasing manager.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Swiss Medica Announces Record Third Quarter Results
Company reports revenues of US$1.77 million compared to US$1.38 million prior year, including success with the company's O24 Pain Neutralizer and launch of PMS Escape in the United States.
- Swiss Medica Announces Record Third Quarter Results
Company reports revenues of US$1.77 million compared to US$1.38 million prior year, including success with the company's O24 Pain Neutralizer and launch of PMS Escape in the United States.
- New Facility for Puresource and NOW Foods
The 11,000 sq ft plant has been developed to meet the current requirements for Natural Health Products Good Manufacturing Practices; Products marketed under the Herbal Select and NOW brands will be produced in this facility.
- New Facility for Puresource and NOW Foods
The 11,000 sq ft plant has been developed to meet the current requirements for Natural Health Products Good Manufacturing Practices; Products marketed under the Herbal Select and NOW brands will be produced in this facility.
- Planet Organic Health Corp Announces Annual Sales Results
Company reports sales of $27.2 million for the year, compared to $12.1 million for the 12-month period last year, increase was driven by acquisitions, store expansions, and same-store sales growth.
- Planet Organic Health Corp Announces Annual Sales Results
Company reports sales of $27.2 million for the year, compared to $12.1 million for the 12-month period last year, increase was driven by acquisitions, store expansions, and same-store sales growth.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- Natural Alternatives International, Inc. Announces First Quarter Results
Company reports net income of $412,000 or $0.06 per diluted share on net sales of $21.7 million, compared to $852,000 or $0.13 per diluted share on net sales of $21.7 million prior year.
- Natural Alternatives International, Inc. Announces First Quarter Results
Company reports net income of $412,000 or $0.06 per diluted share on net sales of $21.7 million, compared to $852,000 or $0.13 per diluted share on net sales of $21.7 million prior year.
- Balchem Corporation Announces Third Quarter 2005 Results
Company reports net sales of $21.1 million and net earnings of $3.0 million ($0.37 per share) for the quarter, Sales of the Encapsulated/Nutritional Products segment were $8.5 million in the period, an increase of 30.7% from the prior year comparable quarter, slowness in nutritional supplement area noted.
- Balchem Corporation Announces Third Quarter 2005 Results
Company reports net sales of $21.1 million and net earnings of $3.0 million ($0.37 per share) for the quarter, Sales of the Encapsulated/Nutritional Products segment were $8.5 million in the period, an increase of 30.7% from the prior year comparable quarter, slowness in nutritional supplement area noted.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- DSM Reports Q3 Results
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004.
- DSM Reports Q3 Results
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004.
- IFF Reports Third Quarter Results
Company reports sales of $493.1 million, declining 3% in comparison to the prior year with fragrance and flavor sales decreased 1% and 3%. Earnings per share were $.72 compared to $.44 in the prior year quarter.
- IFF Reports Third Quarter Results
Company reports sales of $493.1 million, declining 3% in comparison to the prior year with fragrance and flavor sales decreased 1% and 3%. Earnings per share were $.72 compared to $.44 in the prior year quarter.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Weider Nutrition International Announces Name Change to Schiff Nutrition International
Company announces its formal name change to Schiff Nutrition International, Inc.; will retain its current New York Stock Exchange symbol: WNI.
- Weider Nutrition International Announces Name Change to Schiff Nutrition International
Company announces its formal name change to Schiff Nutrition International, Inc.; will retain its current New York Stock Exchange symbol: WNI.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results
Company reports sales for FY06 Q2 were 2,517,000, a decrease of 16% relative to sales of $2,998,000 for the same period of the prior fiscal year, with gross profit of $581,000, compared to a gross profit of $1,054,000 prior year.
- Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results
Company reports sales for FY06 Q2 were 2,517,000, a decrease of 16% relative to sales of $2,998,000 for the same period of the prior fiscal year, with gross profit of $581,000, compared to a gross profit of $1,054,000 prior year.
- GNC Corporation Reports Third Quarter and First Nine Months 2005 Financial Results
Company reports consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, offsetting a 32.4% decline in the diet category in domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
- GNC Corporation Reports Third Quarter and First Nine Months 2005 Financial Results
Company reports consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, offsetting a 32.4% decline in the diet category in domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Arcadia Biosciences Receives NIH Research Grant to Develop Soybean Varieties with Desired Levels of Isoflavones
Company will use its proprietary TILLING(R) advanced screening technology to develop soybean plants that, through genetic variation, contain various levels of soy isoflavones, ranging from very high to very low or none at all.
- Arcadia Biosciences Receives NIH Research Grant to Develop Soybean Varieties with Desired Levels of Isoflavones
Company will use its proprietary TILLING(R) advanced screening technology to develop soybean plants that, through genetic variation, contain various levels of soy isoflavones, ranging from very high to very low or none at all.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
ST. LOUIS, Oct 27, 2005 /PRNewswire-FirstCall via COMTEX/ -- Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility. This collaboration combines each company's unique strengths to bring such a technology to market. "Soy-based products are one of the fastest-growing food industry segments," said Paul Graham, vice president of new business development for The Solae Company. "This agreement will allow us to offer the best tasting, most soluble soy protein on the market, further reinforcing our commitment to drive innovation in food formulation and taste. It is one of several technologies we're using to best meet our customers' needs."
Using advanced plant breeding technology, Monsanto is developing a new soybean with higher levels of beta-conglycinin, designed to improve soy protein flavor and functionality.
"This new product is expected to support -- and help drive -- growing consumer demand for healthier foods," said Jerry Steiner, executive vice president of Monsanto. "It also represents one of several significant products our company is developing to make healthier food more accessible and attractive to consumers."
Soy protein is already used in many food products, including energy bars, meal replacements, soymilk, beverages and meat alternatives. As consumer demand for healthier food options increases, food manufacturers are increasingly looking to formulate products with soy protein.
Few foods have been examined for their nutritional value as thoroughly as soy. Considerable scientific research has demonstrated that a diet rich in soy protein may lead to beneficial health effects, including lowered cholesterol and reduced risk of coronary heart disease. Additional studies are exploring the protein's role in other areas of human nutrition, including obesity prevention.
In addition to bolstering the nutritional value of food products, soy protein offers food manufacturers a number of functional benefits. In soy- based beverages, the ingredient improves taste and facilitates a smoother mouth-feel. In meat products, it contributes to a firmer texture with improved succulence. High beta-conglycinin soy is expected to contribute to these benefits.
"We are pleased to be working with The Solae Company to help food companies create better-tasting foods and beverages and enable more consumers to get the benefits of soy protein," Steiner said.
About the Companies
The Solae Company is a global innovator in the research and application of soy protein. It serves food and beverage manufacturers, dietary supplement developers, retailers and consumers in 80 countries worldwide. Headquartered in St. Louis, Missouri, the company was formed through an alliance between Bunge Limited (BG) and DuPont (DD). For more information, visit http://www.solae.com .
Monsanto Company (MON) is a leading global provider of technology- based solutions and agricultural products that improve farm productivity and food quality. For more information on Monsanto, visit http://www.monsanto.com .
Forward-Looking Statements
This release contains "forward-looking statements" which reflect the companies' current expectations about future performance. These forward- looking statements rely on a number of assumptions and estimates which could be inaccurate and which are subject to risks and uncertainties. Actual results could vary materially from those anticipated or expressed in any forward-looking statement made by the companies due to a number of factors, including without limitation technological uncertainties facing the companies, continued competition in the companies' businesses; the companies' exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the companies' research and development activities; compliance with regulations affecting manufacturing; and the effect of weather conditions, natural disasters and accidents on the agriculture business or facilities. Additional risks and factors related to Monsanto are detailed in Monsanto's filings with the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The Solae Company and Monsanto disclaim any obligation or intent to update the forward- looking statements in order to reflect events or circumstances after the date of this release. |